In the same way that ChatGPT understands human language, a new AI model developed by Columbia computational biologists captures the language of cells to accurately predict their activities.
By generating movies of individual molecules performing actions that make our bodies tick, Columbia researchers have a deeper understanding of a process important in cancer and other diseases.
A new study shows that some of our cells favor genes of one parent or the other and can explain a longstanding mystery of why some people with disease-causing genes experience no symptoms.
Future treatments for hearing loss—including gene therapy—could come to rely on a tiny 3D-printed microneedle designed by a close-knit team of Columbia physicians and engineers.
Under the direction of Donna Farber, PhD, the recently revitalized Division of Surgical Sciences aims to foster basic science research and train a new generation of scientists.
Two research teams at Columbia University Irving Medical Center have received grants from the Chan Zuckerberg Initiative to help build a Human Cell Atlas.
Joachim Frank discusses the call from Sweden and his work using cryo-electron microscopy to reveal the three-dimensional shapes of biological molecules.
Jeffrey Hall, Michael Rosbash, and Michael Young were awarded the 2017 Nobel Prize in Physiology or Medicine for their discoveries of molecular mechanisms controlling circadian rhythm.
Macrophages can eat up to 70 dead cells a day, preventing atherosclerosis. A new CUIMC study finds that mitochondria play a critical role in the process.
Columbia University Irving Medical Center researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action.
Postdoctoral fellow Ewoud Schmidt and graduate student Ori Lieberman received the 2017 Regeneron Prize for Creative Innovation, an award recognizing early-career biomedical scientists.